Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
27.5%
% of HRTS's 41 holdings also in HART
16.7%
% of HART's 75 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus HART)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.1% | 5.4% | 5.4% |
 |
ASTRAZENECA PLC | 4.1% | 5.6% | 4.1% |
 |
NOVO NORDISK A/S-B | 3.9% | 4.0% | 3.9% |
|
ABBOTT LABORATORIES | 3.8% | 5.7% | 3.8% |
|
BOSTON SCIENTIFIC CORP | 3.0% | 5.4% | 3.0% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to HART
|
UNITEDHEALTH GROUP INC | 6.0% |
|
ELI LILLY & CO | 4.7% |
|
BRIDGEBIO PHARMA, INC. | 4.2% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
GILEAD SCIENCES INC | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 3.1% |
|
MERCK & CO. INC. | 2.7% |
|
CRINETICS PHARMACEUTICALS INC | 2.6% |
|
ABBVIE INC | 2.4% |
HRTS Underweight Relative to HART
|
JOHNSON & JOHNSON | -5.3% |
|
ALPHABET INC. CLASS A | -5.0% |
|
PFIZER INC | -5.0% |
|
APPLE INC | -4.9% |
 |
SANOFI-AVENTIS | -4.0% |
|
ELEVANCE HEALTH INC | -2.8% |
|
NIKE INC -CL B | -2.7% |
|
BRISTOL-MYERS SQUIBB CO | -2.5% |
 |
MEDTRONIC PLC | -2.4% |
|
NOVARTIS AG | -2.4% |